Ishara Investments LP — 13F Holdings

2026 Q3  ·  56 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Ishara Investments LP maintained a portfolio of 56 distinct positions. The most significant new addition was TARSUS PHARMACEUTICALS INC, now representing 4.55% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 290.2%. Conversely, Ishara Investments LP completely exited their position in AGIOS PHARMACEUTICALS INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
56
Quarter
2026 Q3
Top Holding
TVTX (7.1%)
Top 10 Concentration
49.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 56

Ishara Investments LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
TVTX
TRAVERE THERAPE...
Healthcare 7.06% 3.42% #1 11
Prev: #12
7.8
—
63,000 76.8%
P
S
145,000 $8,537,600
$40.29 +26.8%
$58.88 -13.2%
2026 Q1 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 6.97% 2.05% #2 19
Prev: #21
7.3
—
95,200 290.2%
P
S
128,000 $8,436,480
$70.85 -27.6%
$65.91 -22.1%
2026 Q2 13F Filing 2026-09-30 2026-11-16
BBIO
BRIDGEBIO PHARM...
Healthcare 5.44% 3.14% #3 11
Prev: #14
6.2
—
42,600 74.2%
P
S
100,000 $6,580,000
$71.51 +8.6%
$65.80 +18.0%
2025 Q4 13F Filing 2026-09-30 2026-11-16
ACAD
ACADIA PHARMACE...
Healthcare 5.33% 7.62% #4 3
Prev: #1
2.6
—
-90,000 -22.0%
P
S
320,000 $6,448,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
TARS
TARSUS PHARMACE...
Healthcare 4.55% — #5
Prev: #—
5.8
—
70,000 —
NEW
70,000 $5,502,700 2025 Q4 13F Filing 2026-09-30 2026-11-16
PTCT
PTC THERAPEUTIC...
Healthcare 4.28% — #6
Prev: #—
5.2
—
80,000 —
NEW
80,000 $5,182,400 2025 Q4 13F Filing 2026-09-30 2026-11-16
PRAX
PRAXIS PRECISIO...
Healthcare 4.09% 5.55% #7 3
Prev: #4
1.6
—
-5,550 -24.6%
P
S
17,000 $4,950,910 2025 Q4 13F Filing 2026-09-30 2026-11-16
VERA
VERA THERAPEUTI...
Healthcare 4.00% 0.32% #8 30
Prev: #38
4.6
—
139,750 1363.4%
P
S
150,000 $4,843,500 2026 Q1 13F Filing 2026-09-30 2026-11-16
ARQT
ARCUTIS BIOTHER...
Healthcare 3.93% — #9
Prev: #—
5.1
—
180,000 —
NEW
180,000 $4,757,400 2025 Q4 13F Filing 2026-09-30 2026-11-16
ANNX
ANNEXON INC
Healthcare 3.92% 3.44% #10 1
Prev: #11
4.1
—
300,000 36.6%
P
S
1,120,000 $4,737,600 2025 Q4 13F Filing 2026-09-30 2026-11-16
UTHR
UNITED THERAPEU...
Healthcare 3.58% — #11
Prev: #—
4.9
—
8,000 —
NEW
8,000 $4,335,120 2025 Q4 13F Filing 2026-09-30 2026-11-16
NAMS
NEWAMSTERDAM PH...
Healthcare 3.22% 0.92% #12 21
Prev: #33
4.3
—
123,100 333.6%
P
S
160,000 $3,891,200 2025 Q4 13F Filing 2026-09-30 2026-11-16
XERS
XERIS BIOPHARMA...
Healthcare 3.16% 7.16% #13 11
Prev: #2
1.3
—
-830,000 -67.5%
P
S
400,000 $3,824,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 3.15% — #14
Prev: #—
4.8
—
48,000 —
NEW
48,000 $3,816,960 2026 Q3 13F Filing 2026-09-30 2026-11-16
DBVT
DBV TECHNOLOGIE...
Healthcare 2.62% 2.22% #15 4
Prev: #19
3.5
—
85,500 46.3%
P
S
270,000 $3,175,200 2026 Q1 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 2.55% — #16
Prev: #—
4.5
—
150,000 —
NEW
150,000 $3,088,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
ZNTL
ZENTALIS PHARMA...
Healthcare 2.47% 3.65% #17 8
Prev: #9
3.0
—
55,000 5.4%
P
S
1,080,000 $2,991,600 2025 Q4 13F Filing 2026-09-30 2026-11-16
BMRN
BIOMARIN PHARMA...
Healthcare 2.38% 6.03% #18 15
Prev: #3
1.0
—
-95,500 -66.6%
P
S
48,000 $2,880,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
BIIB
BIOGEN INC
Healthcare 2.24% — #19
Prev: #—
4.4
—
12,000 —
NEW
12,000 $2,710,560 2026 Q3 13F Filing 2026-09-30 2026-11-16
MLYS
MINERALYS THERA...
Healthcare 2.08% 2.03% #20 2
Prev: #22
1.3
—
-2,500 -2.4%
P
S
100,000 $2,513,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
LGND
LIGAND PHARMACE...
Healthcare 2.07% — #21
Prev: #—
4.3
—
8,000 —
NEW
8,000 $2,498,960 2026 Q1 13F Filing 2026-09-30 2026-11-16
RARE
ULTRAGENYX PHAR...
Healthcare 1.99% 5.03% #22 17
Prev: #5
0.8
—
-45,000 -22.0%
P
S
160,000 $2,404,800 2025 Q4 13F Filing 2026-09-30 2026-11-16
PCVX
VAXCYTE INC
Healthcare 1.88% 3.50% #23 13
Prev: #10
0.8
—
-42,000 -51.2%
P
S
40,000 $2,276,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 1.78% 0.98% #24 8
Prev: #32
3.2
—
37,000 30.1%
P
S
160,000 $2,155,200 2025 Q4 13F Filing 2026-09-30 2026-11-16
AXSM
AXSOME THERAPEU...
Healthcare 1.52% 2.95% #25 10
Prev: #15
0.6
—
-6,400 -39.0%
P
S
10,000 $1,843,900 2026 Q1 13F Filing 2026-09-30 2026-11-16
SLN
SILENCE THERAPE...
Healthcare 1.45% 1.79% #26 3
Prev: #23
3.6
—
104,650 189.1%
P
S
160,000 $1,748,800 2025 Q4 13F Filing 2026-09-30 2026-11-16
BEAM
BEAM THERAPEUTI...
Healthcare 1.41% 1.03% #27 3
Prev: #30
3.6
—
29,000 70.7%
P
S
70,000 $1,711,500 2025 Q4 13F Filing 2026-09-30 2026-11-16
BHVN
BIOHAVEN LTD
Healthcare 1.32% — #28
Prev: #—
4.0
—
120,000 —
NEW
120,000 $1,602,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
RARE
ULTRAGENYX PHAR...
PUT
PUT Option 1.24% — #29
Prev: #—
4.0
—
1,000 —
NEW
1,000 $1,503,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
CTNM
CONTINEUM THERA...
Healthcare 1.20% 2.47% #30 14
Prev: #16
0.5
—
-97,000 -47.3%
P
S
108,000 $1,449,360 2026 Q1 13F Filing 2026-09-30 2026-11-16
GMAB
GENMAB A/S
Healthcare 1.18% 2.07% #31 11
Prev: #20
0.5
—
-62,500 -61.0%
P
S
40,000 $1,427,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
Healthcare 0.94% — #32
Prev: #—
3.9
—
8,000 —
NEW
8,000 $1,134,720 2026 Q3 13F Filing 2026-09-30 2026-11-16
MNPR
MONOPAR THERAPE...
Healthcare 0.79% 0.84% #33 3
Prev: #36
0.8
—
-300 -2.4%
P
S
12,000 $956,040 2026 Q2 13F Filing 2026-09-30 2026-11-16
MLTX
MOONLAKE IMMUNO...
Healthcare 0.77% — #34
Prev: #—
3.8
—
80,000 —
NEW
80,000 $936,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
SPRY
ARS PHARMACEUTI...
Healthcare 0.71% 0.84% #35
Prev: #35
2.8
—
56,510 39.4%
P
S
200,000 $862,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
IONS
IONIS PHARMACEU...
Healthcare 0.59% — #36
Prev: #—
3.7
—
16,000 —
NEW
16,000 $714,400 2026 Q3 13F Filing 2026-09-30 2026-11-16
OLMA
OLEMA PHARMACEU...
Healthcare 0.57% — #37
Prev: #—
3.7
—
80,000 —
NEW
80,000 $691,200 2025 Q4 13F Filing 2026-09-30 2026-11-16
LXRX
LEXICON PHARMAC...
Healthcare 0.50% 2.24% #38 21
Prev: #17
0.2
—
-951,000 -74.8%
P
S
320,000 $600,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
WVE
WAVE LIFE SCIEN...
Healthcare 0.49% 1.40% #39 14
Prev: #25
0.2
—
-168,000 -51.2%
P
S
160,000 $592,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
SVRA
SAVARA INC
Healthcare 0.34% — #40
Prev: #—
3.6
—
80,000 —
NEW
80,000 $412,800 2026 Q3 13F Filing 2026-09-30 2026-11-16
GOSS
GOSSAMER BIO IN...
Healthcare 0.24% 0.10% #41
Prev: #41
0.1
—
-796,000 -97.1%
P
S
24,000 $284,400 2026 Q1 13F Filing 2026-09-30 2026-11-16
MREO
MEREO BIOPHARMA...
Healthcare 0.00% 0.18%
Sold All 😨
(Was: #40)
0.0
—
-768,750 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
IMTX
IMMATICS N.V
Healthcare 0.00% 0.23%
Sold All 😨
(Was: #39)
0.0
—
-30,750 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 0.00% 0.55%
Sold All 😨
(Was: #37)
0.0
—
-41,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
VRTX
VERTEX PHARMACE...
Healthcare 0.00% 0.90%
Sold All 😨
(Was: #34)
0.0
—
-2,460 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
SION
SIONNA THERAPEU...
Healthcare 0.00% 0.99%
Sold All 😨
(Was: #31)
0.0
—
-123,000 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
ALNY
ALNYLAM PHARMAC...
Healthcare 0.00% 1.13%
Sold All 😨
(Was: #29)
0.0
—
-5,125 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 0.00% 1.22%
Sold All 😨
(Was: #28)
0.0
—
-32,800 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
SRRK
SCHOLAR ROCK HL...
Healthcare 0.00% 1.24%
Sold All 😨
(Was: #27)
0.0
—
-30,750 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
NKTR
NEKTAR THERAPEU...
Healthcare 0.00% 1.37%
Sold All 😨
(Was: #26)
0.0
—
-26,650 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 56 holdings

Unlock Full Ishara Investments LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →